Skip to main content
. 2022 Sep 15;14(18):4473. doi: 10.3390/cancers14184473
AAPC average annual percent change
ASR Age-Standardized Rate
CHB chronic hepatitis B
DAA direct-acting antiviral
HBV hepatitis B virus
HCC hepatocellular carcinoma
HCV hepatitis C virus
IFN interferon
NAFLD non-alcoholic liver disease
NAs nucleos(c)ide analogs